Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
United Therapeutics Insider Sold Shares Worth $4,863,730, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $4,863,730, According to a Recent SEC Filing

MT newswireMT newswire2026/08/25 20:42
04:42 PM EDT, 08/25/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on August 24, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $4,863,730. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000127/xslF345X05/primarydocument.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

As the AI trading frenzy subsides, the Nvidia turmoil adds fuel to the fire! Japanese AI stocks face dual scrutiny over valuation and profitability

Investors say that Japanese stocks, which once enjoyed valuation premiums due to their exposure to the artificial intelligence (AI) sector, now seem excessively risky. The sudden resignation of Nvidia CEO Jensen Huang has further intensified market concerns about the outlook for the entire industry.

智通财经•2026/11/19 01:32
As the AI trading frenzy subsides, the Nvidia turmoil adds fuel to the fire! Japanese AI stocks face dual scrutiny over valuation and profitability